Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Pharma Mar SA ( (ES:PHM) ) is now available.
Pharma Mar has continued its previously announced share buyback programme, reporting a series of own-share purchases on the Madrid stock exchange between 1 and 31 January 2026. Over the month, the company executed multiple daily transactions through intermediary JB Capital Markets, acquiring relatively small blocks of shares at average prices generally in the high-70 to low-80 euro range. The operation underscores Pharma Mar’s ongoing capital management strategy and signals confidence in its valuation, with the incremental repurchases potentially supporting earnings per share and providing additional liquidity to shareholders who choose to sell into the programme.
The most recent analyst rating on (ES:PHM) stock is a Hold with a EUR79.00 price target. To see the full list of analyst forecasts on Pharma Mar SA stock, see the ES:PHM Stock Forecast page.
More about Pharma Mar SA
Pharma Mar, S.A. is a Spanish biopharmaceutical company listed on the Madrid stock exchange, focused on the discovery, development and commercialization of oncology drugs derived mainly from marine resources, with a core presence in the European healthcare and capital markets.
Average Trading Volume: 35,716
Technical Sentiment Signal: Buy
Current Market Cap: €1.4B
Find detailed analytics on PHM stock on TipRanks’ Stock Analysis page.